GSP Crop Science Ltd has launched its IPO with a price band of ₹304 to ₹320 per share, aiming to raise ₹400 crore. The IPO is currently open for subscription.
GSP Crop Science is a research-focused agrochemical company engaged in the development and manufacturing of insecticides, herbicides, fungicides, and plant growth regulators. The company has recently launched its Initial Public Offering (IPO), marking a significant step in its growth strategy and offering investors an opportunity to participate in its future endeavors.
The GSP Crop Science IPO is priced within a band of ₹304 to ₹320 per share, with the company aiming to raise a total of ₹400 crore. This amount comprises ₹160 crore reserved for Offer for Sale (OFS) and ₹240 crore to be raised through the issuance of fresh shares. The IPO is structured to allow investors to purchase shares in lots, with each lot consisting of 46 company shares.
As of March 16, 2026, the IPO is open for subscription and will remain available until March 18, 2026. Initial market reactions indicate that the IPO GMP today stands at ₹0, suggesting that shares are trading at par with the issue price. By 2:54 PM on the first day of the subscription, the IPO was subscribed 0.41 times overall, with varying levels of interest across different investor segments.
Specifically, the retail portion of the IPO was filled 0.07 times, while the Non-Institutional Investors (NII) segment saw a subscription rate of 0.19 times. In contrast, the Qualified Institutional Buyers (QIB) segment was more robustly subscribed at 1.19 times. These figures reflect a mixed response from the market, with institutional investors showing a stronger interest compared to retail and NII segments.
Looking ahead, the company has outlined its plans for the proceeds from the IPO. A significant portion, amounting to ₹170 crore, is earmarked for debt reduction, which is expected to strengthen the company’s financial position. As of September 2025, GSP Crop Science reported a net profit of ₹81.07 crore on a total income of ₹847.61 crore for the first half of the fiscal year 2026, indicating a solid operational performance leading up to the IPO.
The most likely date for share allocation is March 19, 2026, with the IPO proposed for listing on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). The anticipated date for the IPO listing is March 23, 2026, which will provide further clarity on the market’s reception of GSP Crop Science’s shares.
As the subscription period continues, observers are keenly watching the developments surrounding the IPO. The varying subscription rates across different segments may influence the final outcome and the company’s market debut. The interest from institutional investors, in particular, could signal confidence in GSP Crop Science’s growth potential and its strategic plans moving forward.
